John Easton

St. Jude Children's Research Hospital

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index72

i10-index141

Publications491

Citations27,333

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 67

Supplementary Figure S4 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Figure S2 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S2 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S12 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Figure S1 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S9 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S3 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S1 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Figure S3 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S4 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S8 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S7 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Data from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S5 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S6 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S10 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S11 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S13 from Cancer Treatment–Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
2026-06-19
Supplementary Table S1 from Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or Somatostatinoma
2026-06-17
Supplementary Table S4 from Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or Somatostatinoma
2026-06-17

Open author page on OpenAlex →